Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus
Viruses of different families encode for regulators of the complement system (RCAs) or acquire such RCAs from the host to get protection against complement-mediated lysis (CML). As hepatitis C virus (HCV) shares no genetic similarity to any known RCA and is detectable at high titers in sera of infec...
Gespeichert in:
Veröffentlicht in: | PloS one 2012-09, Vol.7 (9), p.e45770-e45770 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e45770 |
---|---|
container_issue | 9 |
container_start_page | e45770 |
container_title | PloS one |
container_volume | 7 |
creator | Ejaz, Asim Steinmann, Eike Bánki, Zoltán Anggakusuma Khalid, Sana Lengauer, Susanne Wilhelm, Corinne Zoller, Heinz Schloegl, Anna Steinmann, Joerg Grabski, Elena Kleines, Michael Pietschmann, Thomas Stoiber, Heribert |
description | Viruses of different families encode for regulators of the complement system (RCAs) or acquire such RCAs from the host to get protection against complement-mediated lysis (CML). As hepatitis C virus (HCV) shares no genetic similarity to any known RCA and is detectable at high titers in sera of infected individuals, we investigated whether HCV has adapted host-derived RCAs to resist CML. Here we report that HCV selectively incorporates CD59 while neither CD55, nor CD46 are associated with the virus. The presence of CD59 was shown by capture assays using patient- and cell culture-derived HCV isolates. Association of CD59 with HCV was further confirmed by Western blot analysis using purified viral supernatants from infected Huh 7.5 cells. HCV captured by antibodies specific for CD59 remained infectious for Huh 7.5 cells. In addition, blocking of CD59 in the presence of active complement reduced the titer of HCV most likely due to CML. HCV produced in CD59 knock-down cells were more significantly susceptible to CML compared to wild type virus, but neither replication, assembly nor infectivity of the virus seemed to be impaired in the absence of CD59. In summary our data indicate that HCV incorporates selectively CD59 in its envelope to gain resistance to CML in serum of infected individuals. |
doi_str_mv | 10.1371/journal.pone.0045770 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1326547464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A498251792</galeid><doaj_id>oai_doaj_org_article_9ba5a713571c4d689b19e65e9aff82bd</doaj_id><sourcerecordid>A498251792</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-aed36400fd0c9c08d35ef90d7b5dcdd8c5dbd05cbada8374e9d5168eba0b22543</originalsourceid><addsrcrecordid>eNqNkltv0zAYhiMEYmPwDxBYQkJw0WLHh8Q3k6aOQ6VJEwy4tRwfWldp3NnOxP79HJpNDdoF8kXsz8_7Ov78FsVrBOcIV-jTxvehk-185zszh5DQqoJPimPEcTljJcRPD-ZHxYsYNxBSXDP2vDgqMSS8puy4-H61M8pZp4BU172LLjnfAW-B7Ts1zGULFueUg6ZPoPMpLwgDPgxFCppbsDY7mbIqggW4caGPL4tnVrbRvBq_J8WvL59_Lr7NLi6_LhdnFzPFeJlm0mjMCIRWQ8UVrDWmxnKoq4ZqpXWtqG40pKqRWta4IoZrilhtGgmbsqQEnxRv97671kcxdiMKhEtGSUXYQCz3hPZyI3bBbWW4FV468bfgw0rIkJxqjeCNpLJCmFZIEc1q3iBuGDVcWluXjc5ep-NpfbM1WpkuBdlOTKc7nVuLlb8RmNAaVjQbfBgNgr_uTUxi66IybSs74_v835DTuuScDOi7f9DHbzdSK5kv4Drr87lqMBVn-XFLiipeZmr-CJWHNluncnSsy_WJ4ONEkJlk_qSV7GMUy6sf_89e_p6y7w_YtZFtWkff9kPG4hQke1AFH2Mw9qHJCIoh-ffdEEPyxZj8LHtz-EAPovuo4zuIs_yW</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1326547464</pqid></control><display><type>article</type><title>Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Ejaz, Asim ; Steinmann, Eike ; Bánki, Zoltán ; Anggakusuma ; Khalid, Sana ; Lengauer, Susanne ; Wilhelm, Corinne ; Zoller, Heinz ; Schloegl, Anna ; Steinmann, Joerg ; Grabski, Elena ; Kleines, Michael ; Pietschmann, Thomas ; Stoiber, Heribert</creator><contributor>Marques, Ernesto T.</contributor><creatorcontrib>Ejaz, Asim ; Steinmann, Eike ; Bánki, Zoltán ; Anggakusuma ; Khalid, Sana ; Lengauer, Susanne ; Wilhelm, Corinne ; Zoller, Heinz ; Schloegl, Anna ; Steinmann, Joerg ; Grabski, Elena ; Kleines, Michael ; Pietschmann, Thomas ; Stoiber, Heribert ; Marques, Ernesto T.</creatorcontrib><description>Viruses of different families encode for regulators of the complement system (RCAs) or acquire such RCAs from the host to get protection against complement-mediated lysis (CML). As hepatitis C virus (HCV) shares no genetic similarity to any known RCA and is detectable at high titers in sera of infected individuals, we investigated whether HCV has adapted host-derived RCAs to resist CML. Here we report that HCV selectively incorporates CD59 while neither CD55, nor CD46 are associated with the virus. The presence of CD59 was shown by capture assays using patient- and cell culture-derived HCV isolates. Association of CD59 with HCV was further confirmed by Western blot analysis using purified viral supernatants from infected Huh 7.5 cells. HCV captured by antibodies specific for CD59 remained infectious for Huh 7.5 cells. In addition, blocking of CD59 in the presence of active complement reduced the titer of HCV most likely due to CML. HCV produced in CD59 knock-down cells were more significantly susceptible to CML compared to wild type virus, but neither replication, assembly nor infectivity of the virus seemed to be impaired in the absence of CD59. In summary our data indicate that HCV incorporates selectively CD59 in its envelope to gain resistance to CML in serum of infected individuals.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0045770</identifier><identifier>PMID: 23049856</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Aged ; Antibodies ; Biology ; CD46 antigen ; CD55 Antigens - metabolism ; CD59 antigen ; CD59 Antigens - metabolism ; Cell culture ; Cell Line ; Cell Line, Tumor ; Complement ; Complement Activation ; Complement Inactivator Proteins - immunology ; Complement system ; Complement System Proteins ; Dendritic cells ; Female ; Flow Cytometry - methods ; Gastroenterology ; Genetic aspects ; Genotype ; Hepacivirus - metabolism ; Hepatitis ; Hepatitis C ; Hepatitis C virus ; Hepatology ; HIV ; Hospitals ; Human immunodeficiency virus ; Humans ; Immunoglobulin G - chemistry ; Infections ; Infectivity ; Liver cancer ; Lysis ; Male ; Medicine ; Membrane Cofactor Protein - metabolism ; Middle Aged ; Proteins ; Regulators ; Risk factors ; Signal transduction ; Viral infections ; Virology ; Viruses</subject><ispartof>PloS one, 2012-09, Vol.7 (9), p.e45770-e45770</ispartof><rights>COPYRIGHT 2012 Public Library of Science</rights><rights>Ejaz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2012 Ejaz et al 2012 Ejaz et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-aed36400fd0c9c08d35ef90d7b5dcdd8c5dbd05cbada8374e9d5168eba0b22543</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458075/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458075/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23049856$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Marques, Ernesto T.</contributor><creatorcontrib>Ejaz, Asim</creatorcontrib><creatorcontrib>Steinmann, Eike</creatorcontrib><creatorcontrib>Bánki, Zoltán</creatorcontrib><creatorcontrib>Anggakusuma</creatorcontrib><creatorcontrib>Khalid, Sana</creatorcontrib><creatorcontrib>Lengauer, Susanne</creatorcontrib><creatorcontrib>Wilhelm, Corinne</creatorcontrib><creatorcontrib>Zoller, Heinz</creatorcontrib><creatorcontrib>Schloegl, Anna</creatorcontrib><creatorcontrib>Steinmann, Joerg</creatorcontrib><creatorcontrib>Grabski, Elena</creatorcontrib><creatorcontrib>Kleines, Michael</creatorcontrib><creatorcontrib>Pietschmann, Thomas</creatorcontrib><creatorcontrib>Stoiber, Heribert</creatorcontrib><title>Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Viruses of different families encode for regulators of the complement system (RCAs) or acquire such RCAs from the host to get protection against complement-mediated lysis (CML). As hepatitis C virus (HCV) shares no genetic similarity to any known RCA and is detectable at high titers in sera of infected individuals, we investigated whether HCV has adapted host-derived RCAs to resist CML. Here we report that HCV selectively incorporates CD59 while neither CD55, nor CD46 are associated with the virus. The presence of CD59 was shown by capture assays using patient- and cell culture-derived HCV isolates. Association of CD59 with HCV was further confirmed by Western blot analysis using purified viral supernatants from infected Huh 7.5 cells. HCV captured by antibodies specific for CD59 remained infectious for Huh 7.5 cells. In addition, blocking of CD59 in the presence of active complement reduced the titer of HCV most likely due to CML. HCV produced in CD59 knock-down cells were more significantly susceptible to CML compared to wild type virus, but neither replication, assembly nor infectivity of the virus seemed to be impaired in the absence of CD59. In summary our data indicate that HCV incorporates selectively CD59 in its envelope to gain resistance to CML in serum of infected individuals.</description><subject>Adult</subject><subject>Aged</subject><subject>Antibodies</subject><subject>Biology</subject><subject>CD46 antigen</subject><subject>CD55 Antigens - metabolism</subject><subject>CD59 antigen</subject><subject>CD59 Antigens - metabolism</subject><subject>Cell culture</subject><subject>Cell Line</subject><subject>Cell Line, Tumor</subject><subject>Complement</subject><subject>Complement Activation</subject><subject>Complement Inactivator Proteins - immunology</subject><subject>Complement system</subject><subject>Complement System Proteins</subject><subject>Dendritic cells</subject><subject>Female</subject><subject>Flow Cytometry - methods</subject><subject>Gastroenterology</subject><subject>Genetic aspects</subject><subject>Genotype</subject><subject>Hepacivirus - metabolism</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>Hepatitis C virus</subject><subject>Hepatology</subject><subject>HIV</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immunoglobulin G - chemistry</subject><subject>Infections</subject><subject>Infectivity</subject><subject>Liver cancer</subject><subject>Lysis</subject><subject>Male</subject><subject>Medicine</subject><subject>Membrane Cofactor Protein - metabolism</subject><subject>Middle Aged</subject><subject>Proteins</subject><subject>Regulators</subject><subject>Risk factors</subject><subject>Signal transduction</subject><subject>Viral infections</subject><subject>Virology</subject><subject>Viruses</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNkltv0zAYhiMEYmPwDxBYQkJw0WLHh8Q3k6aOQ6VJEwy4tRwfWldp3NnOxP79HJpNDdoF8kXsz8_7Ov78FsVrBOcIV-jTxvehk-185zszh5DQqoJPimPEcTljJcRPD-ZHxYsYNxBSXDP2vDgqMSS8puy4-H61M8pZp4BU172LLjnfAW-B7Ts1zGULFueUg6ZPoPMpLwgDPgxFCppbsDY7mbIqggW4caGPL4tnVrbRvBq_J8WvL59_Lr7NLi6_LhdnFzPFeJlm0mjMCIRWQ8UVrDWmxnKoq4ZqpXWtqG40pKqRWta4IoZrilhtGgmbsqQEnxRv97671kcxdiMKhEtGSUXYQCz3hPZyI3bBbWW4FV468bfgw0rIkJxqjeCNpLJCmFZIEc1q3iBuGDVcWluXjc5ep-NpfbM1WpkuBdlOTKc7nVuLlb8RmNAaVjQbfBgNgr_uTUxi66IybSs74_v835DTuuScDOi7f9DHbzdSK5kv4Drr87lqMBVn-XFLiipeZmr-CJWHNluncnSsy_WJ4ONEkJlk_qSV7GMUy6sf_89e_p6y7w_YtZFtWkff9kPG4hQke1AFH2Mw9qHJCIoh-ffdEEPyxZj8LHtz-EAPovuo4zuIs_yW</recordid><startdate>20120925</startdate><enddate>20120925</enddate><creator>Ejaz, Asim</creator><creator>Steinmann, Eike</creator><creator>Bánki, Zoltán</creator><creator>Anggakusuma</creator><creator>Khalid, Sana</creator><creator>Lengauer, Susanne</creator><creator>Wilhelm, Corinne</creator><creator>Zoller, Heinz</creator><creator>Schloegl, Anna</creator><creator>Steinmann, Joerg</creator><creator>Grabski, Elena</creator><creator>Kleines, Michael</creator><creator>Pietschmann, Thomas</creator><creator>Stoiber, Heribert</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20120925</creationdate><title>Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus</title><author>Ejaz, Asim ; Steinmann, Eike ; Bánki, Zoltán ; Anggakusuma ; Khalid, Sana ; Lengauer, Susanne ; Wilhelm, Corinne ; Zoller, Heinz ; Schloegl, Anna ; Steinmann, Joerg ; Grabski, Elena ; Kleines, Michael ; Pietschmann, Thomas ; Stoiber, Heribert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-aed36400fd0c9c08d35ef90d7b5dcdd8c5dbd05cbada8374e9d5168eba0b22543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antibodies</topic><topic>Biology</topic><topic>CD46 antigen</topic><topic>CD55 Antigens - metabolism</topic><topic>CD59 antigen</topic><topic>CD59 Antigens - metabolism</topic><topic>Cell culture</topic><topic>Cell Line</topic><topic>Cell Line, Tumor</topic><topic>Complement</topic><topic>Complement Activation</topic><topic>Complement Inactivator Proteins - immunology</topic><topic>Complement system</topic><topic>Complement System Proteins</topic><topic>Dendritic cells</topic><topic>Female</topic><topic>Flow Cytometry - methods</topic><topic>Gastroenterology</topic><topic>Genetic aspects</topic><topic>Genotype</topic><topic>Hepacivirus - metabolism</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>Hepatitis C virus</topic><topic>Hepatology</topic><topic>HIV</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immunoglobulin G - chemistry</topic><topic>Infections</topic><topic>Infectivity</topic><topic>Liver cancer</topic><topic>Lysis</topic><topic>Male</topic><topic>Medicine</topic><topic>Membrane Cofactor Protein - metabolism</topic><topic>Middle Aged</topic><topic>Proteins</topic><topic>Regulators</topic><topic>Risk factors</topic><topic>Signal transduction</topic><topic>Viral infections</topic><topic>Virology</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ejaz, Asim</creatorcontrib><creatorcontrib>Steinmann, Eike</creatorcontrib><creatorcontrib>Bánki, Zoltán</creatorcontrib><creatorcontrib>Anggakusuma</creatorcontrib><creatorcontrib>Khalid, Sana</creatorcontrib><creatorcontrib>Lengauer, Susanne</creatorcontrib><creatorcontrib>Wilhelm, Corinne</creatorcontrib><creatorcontrib>Zoller, Heinz</creatorcontrib><creatorcontrib>Schloegl, Anna</creatorcontrib><creatorcontrib>Steinmann, Joerg</creatorcontrib><creatorcontrib>Grabski, Elena</creatorcontrib><creatorcontrib>Kleines, Michael</creatorcontrib><creatorcontrib>Pietschmann, Thomas</creatorcontrib><creatorcontrib>Stoiber, Heribert</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ejaz, Asim</au><au>Steinmann, Eike</au><au>Bánki, Zoltán</au><au>Anggakusuma</au><au>Khalid, Sana</au><au>Lengauer, Susanne</au><au>Wilhelm, Corinne</au><au>Zoller, Heinz</au><au>Schloegl, Anna</au><au>Steinmann, Joerg</au><au>Grabski, Elena</au><au>Kleines, Michael</au><au>Pietschmann, Thomas</au><au>Stoiber, Heribert</au><au>Marques, Ernesto T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2012-09-25</date><risdate>2012</risdate><volume>7</volume><issue>9</issue><spage>e45770</spage><epage>e45770</epage><pages>e45770-e45770</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Viruses of different families encode for regulators of the complement system (RCAs) or acquire such RCAs from the host to get protection against complement-mediated lysis (CML). As hepatitis C virus (HCV) shares no genetic similarity to any known RCA and is detectable at high titers in sera of infected individuals, we investigated whether HCV has adapted host-derived RCAs to resist CML. Here we report that HCV selectively incorporates CD59 while neither CD55, nor CD46 are associated with the virus. The presence of CD59 was shown by capture assays using patient- and cell culture-derived HCV isolates. Association of CD59 with HCV was further confirmed by Western blot analysis using purified viral supernatants from infected Huh 7.5 cells. HCV captured by antibodies specific for CD59 remained infectious for Huh 7.5 cells. In addition, blocking of CD59 in the presence of active complement reduced the titer of HCV most likely due to CML. HCV produced in CD59 knock-down cells were more significantly susceptible to CML compared to wild type virus, but neither replication, assembly nor infectivity of the virus seemed to be impaired in the absence of CD59. In summary our data indicate that HCV incorporates selectively CD59 in its envelope to gain resistance to CML in serum of infected individuals.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>23049856</pmid><doi>10.1371/journal.pone.0045770</doi><tpages>e45770</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2012-09, Vol.7 (9), p.e45770-e45770 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1326547464 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
subjects | Adult Aged Antibodies Biology CD46 antigen CD55 Antigens - metabolism CD59 antigen CD59 Antigens - metabolism Cell culture Cell Line Cell Line, Tumor Complement Complement Activation Complement Inactivator Proteins - immunology Complement system Complement System Proteins Dendritic cells Female Flow Cytometry - methods Gastroenterology Genetic aspects Genotype Hepacivirus - metabolism Hepatitis Hepatitis C Hepatitis C virus Hepatology HIV Hospitals Human immunodeficiency virus Humans Immunoglobulin G - chemistry Infections Infectivity Liver cancer Lysis Male Medicine Membrane Cofactor Protein - metabolism Middle Aged Proteins Regulators Risk factors Signal transduction Viral infections Virology Viruses |
title | Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T14%3A27%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Specific%20acquisition%20of%20functional%20CD59%20but%20not%20CD46%20or%20CD55%20by%20hepatitis%20C%20virus&rft.jtitle=PloS%20one&rft.au=Ejaz,%20Asim&rft.date=2012-09-25&rft.volume=7&rft.issue=9&rft.spage=e45770&rft.epage=e45770&rft.pages=e45770-e45770&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0045770&rft_dat=%3Cgale_plos_%3EA498251792%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1326547464&rft_id=info:pmid/23049856&rft_galeid=A498251792&rft_doaj_id=oai_doaj_org_article_9ba5a713571c4d689b19e65e9aff82bd&rfr_iscdi=true |